Progyny (PGNY) Research & Development (2018 - 2026)

Progyny (PGNY) has 9 years of Research & Development data on file, last reported at $16.9 million in Q1 2026.

• On a quarterly basis, Research & Development fell 5.07% year-over-year to $16.9 million in Q1 2026; TTM through Mar 2026 was $71.2 million, a 7.44% increase from a year earlier, with the FY2025 full-year figure at $72.1 million, up 12.77% from the prior year.
• Research & Development for Q1 2026 stood at $16.9 million, down from $18.0 million in the prior quarter.
• Over the last five years, Research & Development for PGNY reached as high as $18.4 million in Q2 2025 and fell as low as $10.0 million in Q1 2022.
• Historically, Research & Development has averaged $15.2 million across 5 years, with a median of $15.5 million in 2024.
• Across the five-year window, Research & Development jumped 185.4% in 2022 and retreated 5.07% in 2026, its largest moves.
• Year by year, Research & Development stood at $13.0 million in 2022, then increased by 14.88% to $14.9 million in 2023, then grew by 4.73% to $15.6 million in 2024, then increased by 15.18% to $18.0 million in 2025, then declined by 6.13% to $16.9 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $16.9 million in Q1 2026, $18.0 million in Q4 2025, and $17.9 million in Q3 2025.